Patient Empowerment Through Advocacy: Encourage Your Patients to Join Our Community of ANGELS for Support, Education, and Inspiration.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 19
- By:
- Publication type:
- Article
Works matching IS 21644403 AND DT 2025 AND VI 15 AND IP 1
Results: 16
1
2
A Look Back: Novel FDA Approvals in Oncology, 2024.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 17
- Publication type:
- Article
3
FDA Officials Approve Cosibelimab-ipdl for Metastatic, Locally Advanced Cutaneous Squamous Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 16
- Publication type:
- Article
4
FDA Updates Drug Labeling for Fludarabine Phosphate Under Project Renewal.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 16
- Publication type:
- Article
5
FDA Officials Grant Accelerated Approval to Zanidatamab-hrii for Previously Treated, Unresectable, Metastatic HER2-Positive Biliary Tract Cancer.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 16
- Publication type:
- Article
6
Zenocutuzumab-zbco Earns Accelerated Approval for Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 15
- Publication type:
- Article
7
FDA OKs Durvalumab for Limited-Stage Small Cell Lung Cancer.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 15
- Publication type:
- Article
8
Subgroup Analyses Continue to Support Investigational DLBCL Treatment.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 13
- Publication type:
- Article
9
Study Finds Genetic Changes, Elevated Leukemia Risk in Ground Zero First Responders.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 12
- Publication type:
- Article
10
Financial Trouble, Food Insecurity May Boost Lymphoma-Related ED Trips.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 12
- Publication type:
- Article
11
Survey: MM Patients Open to Cannabis Use, but Oncologists Rarely Discuss It.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 11
- Publication type:
- Article
12
Significant Overall CR Improvement Seen in DLBCL Patients Reported Following Zilovertamab Vedotin Plus R-CHP.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 11
- Publication type:
- Article
13
Daratumumab Dropped Risk of Progression by More Than Half in Smoldering Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 10
- Publication type:
- Article
14
Progression-Free Survival Improved With Addition of Tafasitamab to Lenalidomide and Rituximab.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 10
- Publication type:
- Article
15
Billing for Navigation Services.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 8
- Publication type:
- Article
16
Preparing for Change in Calendar Year 2025.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 6
- By:
- Publication type:
- Article